Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Carolina M Reyes"'
Autor:
Sacha Satram, Parima Ghafoori, Carolina M. Reyes, Tom J. H. Keeley, Helen J. Birch, Dimitra Brintziki, Melissa Aldinger, Elizabeth Alexander, Amanda Lopuski, Elias H. Sarkis, Anil Gupta, Adrienne E. Shapiro, John H. Powers
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract Background The COMET-ICE trial demonstrated that sotrovimab clinically and statistically significantly reduces the risk of all-cause > 24-h hospitalization or death due to any cause among patients with COVID-19 at high risk of disease progre
Externí odkaz:
https://doaj.org/article/6f5b2215640644699e5c1eb8151e8b5b
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Seasonal influenza poses a substantial clinical and economic burden in the United States and vulnerable populations, including the elderly and those with comorbidities, are at elevated risk for influenza-related medical complicati
Externí odkaz:
https://doaj.org/article/2de1b02abfc6461d840691e83853deca
Autor:
Mindy M Cheng, Daniel C Gibbons, Helen Birch, Vishal Patel, Christopher F Bell, Myriam Drysdale, Sacha Satram, Carolina M Reyes
Publikováno v:
Open Forum Infectious Diseases. 9
Background Sotrovimab, a monoclonal antibody (mAb), received Emergency Use Authorization (EUA) for the treatment of high-risk outpatients with symptomatic COVID-19. The study objective was to evaluate real-world effectiveness of sotrovimab (500 mg in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::249080ec3fb220d69532d6b8b23109b8
https://doi.org/10.1093/ofid/ofac492.983
https://doi.org/10.1093/ofid/ofac492.983
Publikováno v:
Journal of Cancer Therapy. 10:1-20
Background: Hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) is the most common biologic subtype of breast cancer. Although adjuvant therapy has demonstrated a survival benefit in clinical trials, its use is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81d85c664282d6e3bd850d0ece13711e
https://doi.org/10.4236/jct.2019.101001
https://doi.org/10.4236/jct.2019.101001
Autor:
Patricia Cortazar, Carolina M. Reyes, Faiyaz Momin, Alisha Stein, Sacha Satram-Hoang, Preeti S. Bajaj
Publikováno v:
Journal of Cancer Therapy. 10:117-133
Purpose: Triple negative breast cancer is more aggressive than other breast cancer subtypes and accounts for up to 20% of all breast cancers. Despite the poorer prognosis, there are no approved targeted treatments available and chemotherapy remains t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3619b80bef33377725ccafc0ca2215a3
https://doi.org/10.4236/jct.2019.102009
https://doi.org/10.4236/jct.2019.102009
Publikováno v:
Journal of Cancer Therapy. :576-587
Background: Bendamustine-based regimens are often used in the management of patients with chronic lymphocytic leukemia (CLL) but few studies have analyzed the comorbidity- and/or adverse event (CAE)-related healthcare costs in patients receiving thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::531620cdfdcb5551193579ef35d57e88
https://doi.org/10.4236/jct.2018.97049
https://doi.org/10.4236/jct.2018.97049
Autor:
Sarang Abhyankar, Vernon F. Schabert, P. Donga, Chun-Lan Chang, Yeun Mi Yim, Carolina M. Reyes, J. Munakata
Publikováno v:
Melanoma Research. 25:312-320
Recent advances have increased treatment options for, and improved clinical outcomes in, metastatic melanoma (mM). Using a large claims database, this retrospective study compared healthcare and adverse event (AE) costs in a US managed care populatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e009aa02851bc444daf6f3411f1297a5
https://doi.org/10.1097/cmr.0000000000000159
https://doi.org/10.1097/cmr.0000000000000159
Publikováno v:
Melanoma Research. 23:159-166
Using a large national claims database, this study investigates the differences in survival and healthcare costs of metastatic melanoma patients by the number of metastatic sites. An analysis was carried out using data obtained from January 2007 to M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0520b329199000bee4b9513844b100
https://doi.org/10.1097/cmr.0b013e32835e58d6
https://doi.org/10.1097/cmr.0b013e32835e58d6
Autor:
D.M. Chen, Lee S. Schwartzberg, Arthur C. Houts, Mark S. Walker, Carolina M. Reyes, D. D. Ramanan
Publikováno v:
Journal of Cancer Therapy. :24-31
Advanced basal cell carcinoma (aBCC) includes metastatic and locally advanced BCC that is inoperable (or with surgery contraindicated). We describe patient characteristics and treatment history for aBCC cases from community oncology. Nine cases of aB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67cfb07c9859745e77b3d239b4796da6
https://doi.org/10.4236/jct.2013.46a1004
https://doi.org/10.4236/jct.2013.46a1004
Publikováno v:
Journal of Cancer Therapy. :1321-1329
Introduction: Chronic lymphocytic leukemia (CLL) is a disease of the elderly. Elderly patients often have increased comorbidity burden and loss of organ reserve that may impact their ability to tolerate cancer therapy. We described realworld characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17468aad84b10808a100632eeb6203fc
https://doi.org/10.4236/jct.2013.48156
https://doi.org/10.4236/jct.2013.48156